Nan Wu

Years Active: 2022-2023
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Jing Zhou, Huiying Bian, Nan Wu
Protein inhibitor of activated STAT3 (PIAS3) attenuates psoriasis and associated inflammation. The Journal of dermatology (2023)
Yunping Chen, Yu Mu, Qing Guan, Chenlong Li, Yangong Zhang, Yinzhi Xu, Chong Zhou, Ying Guo, Yanan Ma, Meiqi Zhao, Guohua Ji, Peng Liu, Donglin Sun, Haiming Sun, Nan Wu, Yan Jin
RPL22L1, a novel candidate oncogene promotes temozolomide resistance by activating STAT3 in glioblastoma. Cell death & disease 14 (11) (2023)
Dongmei Zhang, Yunzhen Zhou, Yanan Ma, Ping Jiang, Hongchao Lv, Sijia Liu, Yu Mu, Chong Zhou, Shan Xiao, Guohua Ji, Peng Liu, Ning Zhang, Donglin Sun, Haiming Sun, Nan Wu, Yan Jin
Ribosomal protein L22-like1 (RPL22L1) mediates sorafenib sensitivity via ERK in hepatocellular carcinoma. Cell death discovery 8 (1) (2022)

Nan Wu.css-eqlu8i{font-size:small;padding-left:4px;}